A new investment case released by ThinkWell presents the case for expanding Malaysia’s National Immunization Program (NIP) to a life-course approach, demonstrating both the economic and societal returns of improved protection. It also outlines practical financing mechanisms, providing decision-makers with actionable pathways to strengthen immunization funding and achieve comprehensive population protection. The case highlights that:
The evidence is clear – life-course immunization delivers strong health and economic returns, yet current funding falls short of protecting Malaysia’s population. Given the challenges facing Malaysia’s healthcare system, adopting a prevention-first approach is essential, and the country must address the current funding gap limiting program expansion. The financing solutions proposed include earmarking taxes for immunization, expanding private sector partnerships, reintroducing a dedicated budget line item for immunization and strengthening financial incentives.
Thumbnail image credit: Shutterstock / Adly Nik II
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.